Thursday, August 27, 2026

Current Affairs 2026

News and Current Affairs for Exams

Today's Current Affairs

Student Of The Week

Sanvi Sharma

This Student is top user of Our App This Week

Current Affairs 2026

News and Current Affairs for Exams

Today's Current Affairs
Headlines
World Lake Day 2026

World Lake Day 2026: Date, History, Significance and Lake Conservation Facts for Exams

SCO Summit 2026 Bishkek

SCO Summit 2026 Bishkek: Dates, Venue, Agenda and Member States

Apoorv Kamble chess tournament

Apoorv Kamble Chess Tournament: FIDE Rated Rapid Chess Winner 2026

Bihar Vidya Sathi App

Bihar Vidya Sathi App Launched for 3 Lakh Students: Key Facts

UP Shadi Anudan Yojana 2026

UP Shadi Anudan Yojana 2026: ₹20,000 Assistance, Eligibility and Documents

US Open 2026 prize money

US Open 2026 Prize Money: Record $108 Million Purse Announced

Meghalaya Assembly uranium mining

Meghalaya Assembly Uranium Mining Resolution: Why the State Opposed KPM Project

Aravalli helicopter engine deal

Aravalli Helicopter Engine Deal: HAL and Safran Sign Agreement for IMRH

indigenous military combat parachute

Indigenous Military Combat Parachute Tested by DRDO in Ladakh

Current Prime Minister of Nepal

Current Prime Minister of Nepal: Who is Balendra Shah?

Nuclear Medicine

Maharashtra cyclotron project Nagpur 2026

Maharashtra Cyclotron Project Nagpur 2026: ₹300 Crore Cancer Care Boost Approved in India

Daily Current Affairs06 mins

Maharashtra cyclotron project Nagpur 2026: The Maharashtra government has approved a ₹300 crore cyclotron project in Nagpur to boost cancer care through advanced radioisotope production for PET-CT scans and nuclear medicine, improving healthcare infrastructure in India. Maharashtra’s Major Push for Advanced Cancer Care Infrastructure in Nagpur Government Approval of ₹300 Crore Cyclotron Project The Maharashtra…

Read Full News
Advanced Prostate Cancer Radioligand Therapy

Advanced Prostate Cancer Radioligand Therapy in India: First Approved Pluvicto Treatment Explained

Daily Current Affairs07 mins

Advanced prostate cancer radioligand therapy in India marks a breakthrough with the approval of Pluvicto. Learn about Lutetium-177, PSMA-targeted treatment, significance, exam relevance, FAQs, and MCQs. Introduction to a Landmark Medical Achievement India has achieved a significant milestone in cancer treatment with the launch of its first regulatory authority-approved radioligand therapy for advanced prostate cancer….

Read Full News